<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Efentakis, Panagiotis</style></author><author><style face="normal" font="default" size="100%">Kremastiotis, Georgios</style></author><author><style face="normal" font="default" size="100%">Varela, Aimilia</style></author><author><style face="normal" font="default" size="100%">Nikolaou, Panagiota-Efstathia</style></author><author><style face="normal" font="default" size="100%">Papanagnou, Eleni-Dimitra</style></author><author><style face="normal" font="default" size="100%">Davos, Constantinos H.</style></author><author><style face="normal" font="default" size="100%">Tsoumani, Maria</style></author><author><style face="normal" font="default" size="100%">Agrogiannis, Georgios</style></author><author><style face="normal" font="default" size="100%">Konstantinidou, Anastasia</style></author><author><style face="normal" font="default" size="100%">Kastritis, Efstathios</style></author><author><style face="normal" font="default" size="100%">Kanaki, Zoi</style></author><author><style face="normal" font="default" size="100%">Iliodromitis, Efstathios K</style></author><author><style face="normal" font="default" size="100%">Klinakis, Apostolos</style></author><author><style face="normal" font="default" size="100%">Dimopoulos, Meletios A</style></author><author><style face="normal" font="default" size="100%">Trougakos, Ioannis P.</style></author><author><style face="normal" font="default" size="100%">Andreadou, Ioanna</style></author><author><style face="normal" font="default" size="100%">Terpos, Evangelos</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">{Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin}</style></title><secondary-title><style face="normal" font="default" size="100%">Blood</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">feb</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://ashpublications.org/blood/article/133/7/710/260578/Molecular-mechanisms-of-carfilzomibinduced</style></url></web-urls></urls><number><style face="normal" font="default" size="100%">7</style></number><volume><style face="normal" font="default" size="100%">133</style></volume><pages><style face="normal" font="default" size="100%">710–723</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">Cfz decreases left ventricular function in mice through increased PP2A activity and inhibition of AMPK$\alpha$/autophagy regulatory axes. Met preserves left ventricular function in mice by restoring AMPK$\alpha$ activation; thus, it emerges as a prophylactic therapy.</style></abstract></record></records></xml>